Clevidipine is an intravenous dihydropyridine calcium channel blocker indicated for the management of severe hypertension in patients who cannot tolerate oral medications. It functions by relaxing vascular… Read more















![Chemical structure of Methyl 2',3'-dichloro-3-methyl-5-oxo-1,2,5,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1801167-49-6-Methyl-23-dichloro-3-methyl-5-oxo-1256-tetrahydro-11-biphenyl-2-carboxylate.png&w=3840&q=75)
![Chemical structure of Methyl 2',3'-dichloro-5-methyl-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1898262-46-8-Methyl-23-dichloro-5-methyl-3-oxo-1236-tetrahydro-11-biphenyl-2-carboxylate.png&w=3840&q=75)

Clevidipine is an intravenous dihydropyridine calcium channel blocker indicated for the management of severe hypertension in patients who cannot tolerate oral medications. It functions by relaxing vascular smooth muscle to effectively lower blood pressure without significant direct cardiac effects. This category offers a comprehensive collection of reference standards, including the active pharmaceutical ingredient, its related process and degradation impurities, metabolites, and stable isotope-labeled compounds. These analytical materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling, method validation, and quality control. Laboratories utilize these stable isotope-labeled compounds as internal standards during liquid chromatography-mass spectrometry assays to ensure precise quantification and accurate identification of impurities. By accessing these diverse reference standards, analytical teams can maintain compliance with regulatory requirements and monitor the quality and stability of pharmaceutical formulations throughout the development and manufacturing lifecycle.